Yui S. Tang

2.6k total citations
18 papers, 580 citations indexed

About

Yui S. Tang is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yui S. Tang has authored 18 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yui S. Tang's work include Neuroscience and Neuropharmacology Research (3 papers), Pain Mechanisms and Treatments (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Yui S. Tang is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Pain Mechanisms and Treatments (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Yui S. Tang collaborates with scholars based in United States, Australia and United Kingdom. Yui S. Tang's co-authors include A. J. Kresge, Jakob Wirz, Yvonne Chiang, Gregory J. Kaczorowski, Ralph A. Stearns, David C. Evans, Richard M. Brochu, María L. García, Ronald C. Hendrickson and Robert G. K. Donald and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Yui S. Tang

18 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yui S. Tang United States 15 235 139 94 80 56 18 580
Ramesh Bambal United States 15 285 1.2× 157 1.1× 55 0.6× 67 0.8× 38 0.7× 30 601
James S. New United States 15 288 1.2× 267 1.9× 122 1.3× 26 0.3× 46 0.8× 30 740
Thomas Ryckmans United Kingdom 15 499 2.1× 305 2.2× 102 1.1× 40 0.5× 72 1.3× 29 877
Clifford Bryant United States 13 385 1.6× 130 0.9× 77 0.8× 30 0.4× 33 0.6× 17 623
James Z. Deng United States 15 289 1.2× 351 2.5× 88 0.9× 29 0.4× 35 0.6× 31 858
Luca Settimo United States 14 273 1.2× 120 0.9× 101 1.1× 19 0.2× 32 0.6× 22 772
Charles F. Barfknecht United States 18 308 1.3× 210 1.5× 178 1.9× 48 0.6× 75 1.3× 62 858
David H. Kinder United States 16 398 1.7× 140 1.0× 61 0.6× 23 0.3× 29 0.5× 40 764
Geoffrey S. Dow United States 15 232 1.0× 237 1.7× 34 0.4× 51 0.6× 39 0.7× 26 778
Richard Svensson Sweden 18 491 2.1× 210 1.5× 81 0.9× 176 2.2× 92 1.6× 42 1.1k

Countries citing papers authored by Yui S. Tang

Since Specialization
Citations

This map shows the geographic impact of Yui S. Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yui S. Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yui S. Tang more than expected).

Fields of papers citing papers by Yui S. Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yui S. Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yui S. Tang. The network helps show where Yui S. Tang may publish in the future.

Co-authorship network of co-authors of Yui S. Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yui S. Tang. A scholar is included among the top collaborators of Yui S. Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yui S. Tang. Yui S. Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Weinglass, Adam B., Martin Köhler, Jessica Liu, et al.. (2008). Madin-Darby Canine Kidney II Cells: A Pharmacologically Validated System for NPC1L1-Mediated Cholesterol Uptake. Molecular Pharmacology. 73(4). 1072–1084. 22 indexed citations
2.
Moore, Eric L., Christopher S. Burgey, Daniel V. Paone, et al.. (2008). Examining the binding properties of MK-0974: A CGRP receptor antagonist for the acute treatment of migraine. European Journal of Pharmacology. 602(2-3). 250–254. 21 indexed citations
3.
Williams, Brande S., John P. Felix, Birgit T. Priest, et al.. (2007). Characterization of a New Class of Potent Inhibitors of the Voltage-Gated Sodium Channel Nav1.7. Biochemistry. 46(50). 14693–14703. 48 indexed citations
4.
Zeng, Zhizhen, Tsing‐Bau Chen, Patricia Miller, et al.. (2006). The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites. Nuclear Medicine and Biology. 33(4). 555–563. 15 indexed citations
5.
Wolkenberg, S. E., Zhijian Zhao, Marianna Kapitskaya, et al.. (2006). Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand. Bioorganic & Medicinal Chemistry Letters. 16(19). 5001–5004. 27 indexed citations
6.
Allocco, John, Robert G. K. Donald, Anita Lee, et al.. (2006). Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro. International Journal for Parasitology. 36(12). 1249–1259. 47 indexed citations
7.
Doss, George A., Randall R. Miller, Zhoupeng Zhang, et al.. (2005). Metabolic Activation of a 1,3-Disubstituted Piperazine Derivative:  Evidence for a Novel Ring Contraction to an Imidazoline. Chemical Research in Toxicology. 18(2). 271–276. 27 indexed citations
8.
Chen, Qing, George A. Doss, Yui S. Tang, et al.. (2005). EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS. Drug Metabolism and Disposition. 34(1). 145–151. 38 indexed citations
9.
Sandhu, Punam, Xin Xu, Suresh K. Balani, et al.. (2004). Disposition of Caspofungin, a Novel Antifungal Agent, in Mice, Rats, Rabbits, and Monkeys. Antimicrobial Agents and Chemotherapy. 48(4). 1272–1280. 40 indexed citations
10.
Samuel, Koppara, Ralph A. Stearns, Yui S. Tang, et al.. (2003). Addressing the metabolic activation potential of new leads in drug discovery: a case study using ion trap mass spectrometry and tritium labeling techniques. Journal of Mass Spectrometry. 38(2). 211–221. 53 indexed citations
12.
Schmalhofer, William A., Robert S. Slaughter, Mary E. Matyskiela, et al.. (2003). Di-Substituted Cyclohexyl Derivatives Bind to Two Identical Sites with Positive Cooperativity on the Voltage-Gated Potassium Channel, Kv1.3. Biochemistry. 42(16). 4733–4743. 16 indexed citations
13.
Smith, McHardy M., Vivien A. Warren, Richard M. Brochu, et al.. (2000). Nodulisporic Acid Opens Insect Glutamate-Gated Chloride Channels:  Identification of a New High Affinity Modulator. Biochemistry. 39(18). 5543–5554. 53 indexed citations
14.
Kinder, Frederick R., et al.. (1992). Synthesis of carbon‐14 and tritium analogues of the phospholipid antitumor agent SDZ 62‐834 zi. Journal of Labelled Compounds and Radiopharmaceuticals. 31(10). 829–835. 4 indexed citations
15.
Arrowsmith, C.H., Lars Baltzer, A. J. Kresge, Michael F. Powell, & Yui S. Tang. (1986). Tritium isotope effects on carbon-13 NMR chemical shifts. Journal of the American Chemical Society. 108(6). 1356–1357. 7 indexed citations
16.
Long, Mervyn A., et al.. (1984). Simple modification of a gas chromatography for radio-assay of tritiumlabelled compounds. Journal of Chromatography A. 287. 381–384. 7 indexed citations
17.
Chiang, Yvonne, A. J. Kresge, Yui S. Tang, & Jakob Wirz. (1984). The pKa and keto-enol equilibrium constant of acetone in aqueous solution. Journal of the American Chemical Society. 106(2). 460–462. 91 indexed citations
18.
Tang, Yui S., et al.. (1983). N‐succinimidyl propionate: Characterisation and optimum conditions for use as a tritium labelling reagent for proteins. Journal of Labelled Compounds and Radiopharmaceuticals. 20(2). 277–284. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026